Analyst Ratings for Sarepta Therapeutics
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 24 analysts have published their opinion on Sarepta Therapeutics (NASDAQ:SRPT) stock. The analysts have an average price target of $183.42 versus the current price of Sarepta Therapeutics at $107.69, implying an upside. This current average has increased by 3.45% from the previous average price target of $177.31.
August 04, 2023 | 1:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have a bullish outlook on Sarepta Therapeutics with an average price target of $183.42, indicating a potential upside from the current price of $107.69.
The bullish outlook from analysts indicates a positive sentiment towards Sarepta Therapeutics. The average price target is significantly higher than the current price, suggesting that the stock is undervalued and has potential for growth. This could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100